EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis

Jun Shao, Chuanbin Liu, Jing Wang iD

Cancer Innovation · 2023

DOI: 10.1002/cai2.100 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Innovation, 2023. Verfasst von Jun Shao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine First Medical Center of PLA General Hospital Beijing China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune checkpoint inhibitors (ICIs) play a crucial role in the immunotherapy of malignant tumors, preventing immune evasion by tumor cells and activating autoimmune cells to eliminate the tumor. Despite their proven effectiveness in antitumor therapy, potential immune‐related adverse effects must be recognized, particularly ICI‐associated myocarditis (ICIAM). ICIAM is the most lethal form of organ immunotoxicity, with a significant impact on short‐term mortality. However, ICIAM is predominantly asymptomatic or mildly nonspecific. It is difficult to diagnose, especially due to the lack of unique molecular markers. This article aims to provide a comprehensive overview of the progress made in identifying molecular markers for ICIAM.

Schlagwörter

Stichwörter der Autor:innen

immune checkpoint inhibitorsmolecular markermyocarditistumor immunotherapy

Autor:innen und Institutionen

  • Department of General Medicine First Medical Center of PLA General Hospital Beijing China.
  • Western Medical Branch of PLA General Hospital Beijing China.

ORCID-Profile: Jing Wang

Zitieren

APA

Shao, J., Liu, C., & Wang, J. (2023). Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis. Cancer Innovation. https://doi.org/10.1002/cai2.100

Vancouver

Shao J, Liu C, Wang J. Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis. Cancer Innovation. 2023. doi:10.1002/cai2.100

BibTeX
@article{Shao2023,
  author = {Shao, Jun and Liu, Chuanbin and Wang, Jing},
  title = {Advances in research on molecular markers in immune checkpoint inhibitor‐associated myocarditis},
  journal = {Cancer Innovation},
  year = {2023},
  doi = {10.1002/cai2.100}
}
Kostenlos starten →